文献速递结核与非结核分枝杆菌

血液转录组分层可预测结核接触者短期发病风险

Blood Transcriptomic Stratification of Short-term Risk in Contacts of Tuberculosis.
PubMed 文献 · Clin Infect Dis · 2020-01-01

研究结合已发表数据与英国333例HIV阴性结核接触者前瞻队列,用稳定性选择法识别由BATF2、GBP5、SCARF1组成的3基因转录特征;该特征在独立队列预测90天内进展的PPV为23%,在新队列预测活动性结核的PPV为50%、NPV为99.3%,优于IGRA的PPV 5.6%。

要点

  • 3基因转录特征可分层结核接触者短期发病风险。
  • 该特征NPV达99.3%,有助于排除低风险者。
  • 其PPV优于外周血IGRA,可指导预防性治疗。

核心结论

  • 血液3基因转录特征BATF2、GBP5、SCARF1可对结核接触者短期发病风险进行分层,优于外周血IGRA。

研究设计与样本

  • 结合已发表血液转录组数据与英国333例HIV阴性结核接触者前瞻队列,中位随访346天,用稳定性选择识别短期风险特征并在独立队列评估。

主要发现

  • 南非HIV阴性无症状结核感染病例对照研究中,3基因特征预测90天内进展为活动性结核的PPV为23%。
  • 英国333例HIV阴性接触者队列中,该特征预测活动性结核的PPV为50%(95%CI 15.7-84.3),NPV为99.3%(95%CI 97.5-99.9)。
  • 同队列外周血IGRA的PPV为5.6%(95%CI 2.1-11.8)。

关键数值与推荐

  • 3基因转录特征:BATF2、GBP5、SCARF1。
  • 南非队列预测90天内进展的PPV为23%。
  • 英国队列PPV 50%(95%CI 15.7-84.3),NPV 99.3%(95%CI 97.5-99.9)。
  • 同队列IGRA的PPV为5.6%(95%CI 2.1-11.8)。

临床怎么用

  • 可考虑用该血液转录特征对HIV阴性结核接触者进行短期发病风险分层,高PPV者优先靶向预防性治疗,高NPV者或可减少干预。

局限性

  • 英国验证队列为HIV阴性人群,样本量333例,结果外推需谨慎;南非数据为已发表病例对照研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The highest risk of tuberculosis arises in the first few months after exposure. We reasoned that this risk reflects incipient disease among tuberculosis contacts. Blood transcriptional biomarkers of tuberculosis may predate clinical diagnosis, suggesting they offer improved sensitivity to detect subclinical incipient disease. Therefore, we sought to test the hypothesis that refined blood transcriptional biomarkers of active tuberculosis will improve stratification of short-term disease risk in tuberculosis contacts. METHODS: We combined analysis of previously published blood transcriptomic data with new data from a prospective human immunodeficiency virus (HIV)-negative UK cohort of 333 tuberculosis contacts. We used stability selection as an alternative computational approach to identify an optimal signature for short-term risk of active tuberculosis and evaluated its predictive value in independent cohorts. RESULTS: In a previously published HIV-negative South African case-control study of patients with asymptomatic Mycobacterium tuberculosis infection, a novel 3-gene transcriptional signature comprising BATF2, GBP5, and SCARF1 achieved a positive predictive value (PPV) of 23% for progression to active tuberculosis within 90 days. In a new UK cohort of 333 HIV-negative tuberculosis contacts with a median follow-up of 346 days, this signature achieved a PPV of 50% (95% confidence interval [CI], 15.7-84.3) and negative predictive value of 99.3% (95% CI, 97.5-99.9). By comparison, peripheral blood interferon gamma release assays in the same cohort achieved a PPV of 5.6% (95% CI, 2.1-11.8). CONCLUSIONS: This blood transcriptional signature provides unprecedented opportunities to target therapy among tuberculosis contacts with greatest risk of incident disease.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Roe J, Venturini C, Gupta RK, et al. Blood Transcriptomic Stratification of Short-term Risk in Contacts of Tuberculosis. Clin Infect Dis. 2020. PMID: 30919880. doi:10.1093/cid/ciz252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。